NCT01414868
- Conditions
- Asthma, Bronchial Asthma, Bronchial Diseases, +7 more
- Locations
-
- The First Affiliated Hospital of Guangzhou Medical College Guangzhou, Guangdong, China
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,948 public trials
736 recruiting studies
Lung Diseases, Obstructive trial results
Completed
AZD2115 Single Ascending Dose Study
NCT01283984
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +9 more
- Locations
-
- Research Site London, UK, United Kingdom
NCT00821093
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +10 more
- Locations
-
- Novartis Investigator Site Anniston, Alabama, United States
- Novartis Investigator Site Fairhope, Alabama, United States
- Novartis Investigator Site Jasper, Alabama, United States
- Novartis Investigator Site Mobile, Alabama, United States
NCT00622635
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigator Site Normal, Illinois, United States
- Novartis Investigator Site Shawnee Mission, Kansas, United States
- Novartis Investigator Site Lafayette, Louisiana, United States
- Novartis Investigator Site Charlotte, North Carolina, United States
NCT01156844
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +7 more
- Locations
-
- Novartis Investigative Site Anniston, Alabama, United States
- Novartis Investigative Site Cypress, California, United States
- Novartis Investigative Site Fresno, California, United States
- Novartis Investigative Site San Diego, California, United States
NCT00403845
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigative site Kasukabe, Japan
- Novartis Investigator Site Kishiwada, Japan
- Novartis Investigative Site Kurume, Japan
- Novartis Investigative Site Obihiro, Japan
NCT00792805
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Adelaide, Australia
- Novartis Investigative Site Clayton, Australia
- Novartis Investigative Site Daw Park, Australia
- Novartis Investigative Site Beijing, China
NCT01418469
- Conditions
- Behavior, Chronic Disease, Chronic Obstructive Pulmonary Disease, +8 more
- Locations
-
- Maastricht UMC Maastricht, Netherlands
NCT00620022
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Novartis Investigator Site Torrance, California, United States
- Novartis Investigator Site Lebanon, New Hampshire, United States
- Novartis Investigator Site Brussels, Belgium
- Novartis Investigator Site Gembloux, Belgium
Completed
Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00794157
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Novartis Investigator Site Hong Kong
- Novartis Investigator Site New Territories, Hong Kong
- Novartis Investigative Site Ahmedabad, India
- Novartis Investigator Site Bangalore, India